- Home
- CLPS vs DTIL Comparison
CLPS vs DTIL Comparison
Compare CLPS & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- DTIL
- Stock Information
- Founded
- CLPS 2005
- DTIL 2006
- Country
- CLPS Hong Kong
- DTIL United States
- Employees
- CLPS N/A
- DTIL N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- CLPS Technology
- DTIL Health Care
- Exchange
- CLPS Nasdaq
- DTIL Nasdaq
- Market Cap
- CLPS 38.4M
- DTIL 44.1M
- IPO Year
- CLPS 2018
- DTIL 2019
- Fundamental
- Price
- CLPS $1.12
- DTIL $4.33
- Analyst Decision
- CLPS
- DTIL Strong Buy
- Analyst Count
- CLPS 0
- DTIL 2
- Target Price
- CLPS N/A
- DTIL $39.50
- AVG Volume (30 Days)
- CLPS 28.5K
- DTIL 104.8K
- Earning Date
- CLPS 10-18-2024
- DTIL 11-04-2024
- Dividend Yield
- CLPS 11.71%
- DTIL N/A
- EPS Growth
- CLPS N/A
- DTIL N/A
- EPS
- CLPS N/A
- DTIL 1.45
- Revenue
- CLPS $142,812,726.00
- DTIL $75,096,000.00
- Revenue This Year
- CLPS N/A
- DTIL $50.33
- Revenue Next Year
- CLPS N/A
- DTIL N/A
- P/E Ratio
- CLPS N/A
- DTIL $3.21
- Revenue Growth
- CLPS N/A
- DTIL 43.62
- 52 Week Low
- CLPS $0.68
- DTIL $4.56
- 52 Week High
- CLPS $1.70
- DTIL $19.43
- Technical
- Relative Strength Index (RSI)
- CLPS 46.98
- DTIL 24.26
- Support Level
- CLPS $1.05
- DTIL $5.12
- Resistance Level
- CLPS $1.15
- DTIL $6.18
- Average True Range (ATR)
- CLPS 0.05
- DTIL 0.46
- MACD
- CLPS 0.01
- DTIL -0.13
- Stochastic Oscillator
- CLPS 68.75
- DTIL 5.21
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting service, Customized IT solution service, and other. Generating majority of its revenue from the IT consulting service.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.